Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation

S.K. Singh, J. Stephani, M. Schaefer, H. Kalay, J.J. Garcia Vallejo, J.M.M. den Haan, E. Saeland, T. Sparwasser, Y. van Kooyk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)164-174
JournalMolecular Immunology
Volume47
Issue number2-3
DOIs
Publication statusPublished - 2009

Cite this